Efficacy News and Research

RSS

Edible coatings will be the packaging of the future

The growing demand by consumers for healthier and more ecological foods has driven researchers to develop new systems of packaging that prolong the useful life of the products and that are, at the same time, recyclable.

4 Sep 2006

U.S. Army to trial of Glypromate to reduce brain injury from cardiac arrest

Neuren Pharmaceuticals today announced that physicians from Madigan Army Medical Center (Madigan) in Tacoma, Washington, will conduct an investigator- initiated Phase 2 trial to determine the safety and efficacy of Glypromate in reducing brain injury caused by out of hospital cardiac arrest.

4 Sep 2006

Cancer Research Technology announce colorectal cancer research collaboration with AstraZeneca

Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with AstraZeneca focused on colorectal cancer.

4 Sep 2006

New developments in the technique of partial nephrectomy

While partial nephrectomy has demonstrated oncologic equipoise with radical nephrectomy, it remains a surgically daunting procedure that can be associated with significant complications, particularly related to hemostasis and prevention of post-operative urinary fistulae.

1 Sep 2006

Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic

Emergent BioSolutions has announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases (NIAID) totaling $3.8 million to support the development of the company's anthrax immune globulin (AIG) therapeutic product.

1 Sep 2006

March of Dimes urges FDA to approve Gestiva

The March of Dimes has urged Food and Drug Administration officials to promptly approve a commercial progesterone therapy that appears to prevent some premature births.

30 Aug 2006

VIOXX reduces risk of colorectal polyps

A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.

30 Aug 2006

Summary of editorials on approval of nonprescription plan B sales to women over age 18

Some editorials respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.

30 Aug 2006

Benefits, misconceptions, frequency of condom use to protect against unplanned pregnancy, STIs

The New York Times on Tuesday examined the benefits and misconceptions of condom use to protect against sexually transmitted infections, including HIV, and unplanned pregnancy.

24 Aug 2006

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

The National Women's Health Network has petitioned FDA to stop sales of Solvay's Estratest and Breckenridge Pharmaceuticals' Syntest, which are estrogen-testosterone combination therapies used to treat menopause-associated hot flashes, until they are proven safe and effective, Reuters reports.

24 Aug 2006

Simpler and less expensive method of controlling the progression of HIV

There might be a simpler and less expensive method of controlling the progression of HIV, according to several preliminary studies presented last Thursday at the XVI International AIDS Conference in Toronto, the Los Angeles Times reports (Chong, Los Angeles Times, 8/18).

20 Aug 2006

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Because of their high content of antioxidants, pomegranate juice is frequently recommended for cancer prevention and overall wellness. While small studies have suggested a role against prostate carcinogenesis, no organized trials have been published until now.

17 Aug 2006

Link between male circumcision and protection against HIV infection

In June 2006, the US National Institutes of Health announced that, following an interim review, two ongoing trials in Uganda and Kenya examining the link between male circumcision and the risk of acquisition of HIV infection in men should be continued.

17 Aug 2006

Male circumcision, microbicides and other tools set to change HIV prevention landscape

In a new report released this week, fifty top AIDS experts warn that a range of promising new HIV prevention approaches are nearing completion of clinical trials, but the world is unprepared to ensure widespread access for those in need.

15 Aug 2006

Argatroban may promote opening of arteries following stroke

A medication known as argatroban, when combined with another drug already used in the treatment of stroke patients, may help restore the flow of blood through blocked arteries.

14 Aug 2006

Varenicline shown to help 'quit smoking'

A drug recently approved by the U.S. Food and Drug Administration as an aid to smoking cessation appears effective both short- and long-term for smokers trying to quit, according to two reports in the August 14/28 issue of the Archives of Internal Medicine.

14 Aug 2006

Efficacy News and Research

Edible coatings will be the packaging of the future

U.S. Army to trial of Glypromate to reduce brain injury from cardiac arrest

Cancer Research Technology announce colorectal cancer research collaboration with AstraZeneca

New developments in the technique of partial nephrectomy

Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic

March of Dimes urges FDA to approve Gestiva

VIOXX reduces risk of colorectal polyps

Summary of editorials on approval of nonprescription plan B sales to women over age 18

Benefits, misconceptions, frequency of condom use to protect against unplanned pregnancy, STIs

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

Simpler and less expensive method of controlling the progression of HIV

Pomegranate juice may decrease PSA progression in patients with cancer recurrence after treatment

Link between male circumcision and protection against HIV infection

Male circumcision, microbicides and other tools set to change HIV prevention landscape

Argatroban may promote opening of arteries following stroke

Varenicline shown to help 'quit smoking'

New program tackles HIV prevention among Latino adolescents

New national standard for handling substances suspected of being biological threat agents

HIV virus can survive efforts to destroy it by hiding in the mucosal tissues of the intestine

Txr1 gene that affects human cancer cells' sensitivity to chemotherapy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News